RxDoctor Payments DataLook up a doctor →

Gary Simmons, DO

Hematology & Oncology · Norfolk, VANPI 1770802373

Payments from drug & device makers

$709,663in general payments, 2019–2025

Across 88 payments — averaging $8064.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Beigene, Ltd.$458K
  • Gilead$72K
  • Beone Medicines Ltd.$52K
  • Bristol Myers Squibb$48K
  • AbbVie$36K
  • Mckesson Sourcing Services, Inc.$32K
  • plus $12K from 8 others
$1,126in research payments, 2019–2025

Across 9 payments — averaging $125.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$709,663 in reported general payments places this provider in the 85th percentile of 293 hematology & oncology providers in Virginia.

See all hematology & oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$8,918,249
Medicare patients
428
Services billed
176,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →